Division Announcements

WashU ID welcomes the Gerald Medoff Visiting Professor, Dr. Cesar A. Arias

Cesar A. Arias, MD, MSc, PhD, Professor of Medicine at Wiell Cornell Medical College spoke at medicine grand rounds on October 3. The title of his talk was “Translational Approach to Antimicrobial Resistance: A Clinician Conundrum”.

The grand rounds — part of the Gerald Medoff Visiting Professor grand rounds lecture series — was free and open to the general public but geared toward Washington University and BJC HealthCare employees, residents, fellows and students.

Dr. Arias is the founder and scientific advisor of the Molecular Genetics and
Antimicrobial Resistance Unit/International Center for Microbial Genomics at
Universidad El Bosque, Bogota, Colombia. Dr. Arias earned his MD from Universidad
El Bosque, Bogota, Colombia, where he is currently an adjunct professor, and his PhD
from the University of Cambridge, United Kingdom. He is an internationally recognized
expert on mechanisms of antibiotic resistance with emphasis on Gram-positive
organisms, the clinical impact of resistance, and the molecular epidemiology of
antibiotic-resistant organisms. Dr. Arias has more than 200 publications in the field.

ID Division leadership and faculty join Dr. Arias following his presentation.

Dr. Arias is the Editor In Chief of Antimicrobial Agents and Chemotherapy, a peer-reviewed scientific journal published by the American Society for Microbiology. It covers antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy.

Dr. Arias was inducted into the American Society for Clinical Investigation in 2015 and became a Fellow of the American Academy of Microbiology in 2019.

More on Dr. Arias from the American Society for Microbiology.


Gerald Medoff, MD, a physician scientist and one of the founding leaders of the Mycosis Study Group, was the ID Division Director for more than 20 years at Washington University School of Medicine (WUSM). Dr. Medoff fostered the first WUSM AIDS Clinical Trials Unit, HIV clinic and HIV/AIDS Advocacy. He provided leadership and training for programs that were novel 20 years ago, the BJH Antimicrobial Stewardship, Infection Prevention, Pharmacy & Therapeutics, and Quality & Safety Committees.